AEGiS-UPI: Tick disease poses threat to blood supply United Press InternationalImportant note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
Click here to return to United Press International main menu
DonateNow
Print this article




Tick disease poses threat to blood supply

United Press International - July 29, 2002
Steve Mitchell, UPI Medical Correspondent


A potentially fatal disease spread by ticks may be on the increase and government and public health officials are concerned it could be infiltrating the blood supply.

Babesiosis, a mild malaria-like illness, is transmitted by Ixodes scapularis, the black-legged tick, the same creature that carries Lyme disease. So far, babesiosis largely has been confined to Nantucket and Martha's Vineyard, Mass., and parts of Long Island, N.Y.

In recent years, however, the tiny black-legged ticks -- also called deer ticks -- that carry the disease appear to be expanding their range, Sam Telford, a researcher at Harvard University, in Cambridge, Mass., who focuses on tickborne diseases, told United Press International.

"We do believe it's probably spreading," Peter Krause of the Connecticut Children's Medical Center in Hartford and the University of Connecticut School of Medicine in Farmington, told UPI. Krause noted people have become infected with the disease in New Jersey and farther inland in Connecticut, indicating it is spreading westward in that state.

This raises concern on two levels. People who pick up the disease from a tick are at risk of death because the disease can be fatal in 5 percent of cases and there is a risk they could transmit the protozoan that causes the disease to others if they donate blood, Krause said.

More than 30 cases of people contracting the disease through blood transfusions have been documented but the total number of cases is likely much higher because the disease often goes unrecognized and unreported, he said. In most people, the disease causes fever and aches for about a week, but it can have severe consequences and some people may have to be placed on life support.

"This disease is definitely underestimated," Krause said. "There are more cases than we realize and it's increasing." He added many physicians are becoming more aware of the disease and more labs are starting to test for it, "so we're going to be seeing more cases just because of increased recognition. Scientists know the risk of transmitting babesiosis via blood transfusions is a problem ... and they are looking for ways to decrease the possibility of this."

Krause noted both the American Red Cross and the Centers for Disease Control and Prevention in Atlanta are involved in a study to determine the prevalence of the disease and the risk posed to the blood supply.

Barbara Herwaldt, a medical epidemiologist with the CDC, told UPI the threat of babesiosis getting into the blood supply is "of concern," but she declined to elaborate further on the study or how much of a risk contaminated blood poses to the general population.

The Red Cross did not respond to phone calls from UPI seeking comment. Other blood bank organizations also are worried about the threat of babesiosis.

"It is relatively high on our priority list for transfusion infections," said Louis Katz, vice president of medical affairs at the Mississippi Valley Regional Blood Center in Davenport, Iowa, and chair of the American Association of Blood Banks transfusion/transmitted diseases committee.

"The reason it is an issue in blood banking now is due to environmental and demographic changes over the past years and people are now living where ticks are," Katz said. This means babesiosis infections are increasing so it is more likely infected people will donate blood, he said.

Although there is no test for screening blood for babesiosis, the Food and Drug Administration does require blood centers to ask about the disease and bar people from donating if they report ever having the disease, an FDA spokesman told UPI. However, this may not catch everyone infected with the disease because often people will catch it but the symptoms are so minor they do not realize they are infected, Krause said.

The FDA spokesman stressed, "The benefit of receiving a blood transfusion far outweighs any theoretical risk associated with receiving that transfusion." But he said, "The FDA would be very interested in a blood screening test (for babesiosis) being brought forward for evaluation," adding the agency is attempting to develop such a test.

People at greatest risk of contracting babesiosis via blood transfusions are the elderly, patients whose spleens have been removed and those with weakened immune systems due to surgery, cancer or HIV/AIDS, Krause said. In these patients, babesiosis is more likely to cause serious health problems or death. The disease also could interfere with recovery from surgery.

Krause said children also are at risk of contracting the disease but they seem to be protected from the serious complications.

Scientists likely will continue to focus on babesiosis in the near future.

Telford said "the disease will get a lot of interest" next month at an international conference on Lyme and other tickborne diseases in New York City.

He also predicted it will continue to spread and become more of an issue with the public at large.


020729
UP020730


Copyright © 2002 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .